income in an amount of 747.94 million baht. In the third quarter of 2019, finance cost was increased in an amount of 56.74 million baht came from the issuance of Debentures in the amount of 6,000 million
and production had increased as well. But production stumbled again by the end of the year, and we are now just seeing signs for recovery in end of February 2020, for which production is expected to
margin (excluding depreciation) in Q2-2017 was achieved at THB 834/ton, lower by 80% from last year quarter. - Sale volumes (Coil tons) in Q2-2017 achieved at 315,610 tons which were a slightly increased
increased by 12.3% compared to average revenue generated per out-patients visits. On the contrary, the proportion of revenues incurred compared to number of in-patients was decreased by 0.9%. Cost of Hospital
of Baht 337.30 million. Administrative expenses increased of Baht 14.94 million (Most of the costs will be as staff salaries. Auditing fee and financial advisory fee) and financial expenses increased
length of stay. Furthermore, there have been an increasing numbers of suggestions towards OPD treatments. However, the revenue of OPD increased by 12.2% comparing to the same period last year due to the
100 MB Capital increased by FVC to HHC at 150 MB The aforesaid funding gained by FVC’s capital increased by Right Offering approved by the shareholders at AGM 2017 10. Condition of Doing the
administrative expenses for 1Q19 was Baht 111.29 million, increased from previous period. The increase was mainly due to the expenses of new outlets (i.e. Rayong and Diana branches) such as depreciation, utilities
THB 164m in Q1 2019 from THB 343m in Q1 2018. Net Profit decreased 45% to THB 303m in Q119 from THB 553m in Q118, due to higher costs due to increased capacity in Q119 compared to Q118 and THB
unit has increased. In 1H19, the Company’s gross profit margin was 36.88%, which slightly increased from 1H18 (at 36.58%). Such increase in gross profit margin was mainly attributed to a decrease in